510(k) K812837
K812837 is an FDA 510(k) premarket notification submitted by Anco Medical Reagents & Assoc. for the device "ALKALINE PHOSPHATASE REAGENT SET". The FDA issued a decision of Substantially Equivalent on January 29, 1982. The device falls under product code CJL (Beta Glycerophosphate, Alkaline Phosphatase Or Isoenzymes), a Class II device regulated under 21 CFR 862.1050. Anco Medical Reagents & Assoc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- January 29, 1982
- Date Received
- October 9, 1981
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Beta Glycerophosphate, Alkaline Phosphatase Or Isoenzymes
- Device Class
- Class II
- Regulation Number
- 862.1050
- Review Panel
- CH
- Submission Type